Business Context and Reporting Period
This Form 6-K filing is submitted by Hexindai Inc., a foreign private issuer, for the month of November 2018. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on November 13, 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing includes a press release as Exhibit 99.1.
Key Financial Metrics
The provided filing text contains only the cover page and exhibit index. It does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for any financial metric.
Material Changes
No material changes versus the prior comparable period are described in the provided text, as the document lacks financial data or operational updates beyond the inclusion of a press release.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details regarding unusual items. These details are likely contained within the referenced Exhibit 99.1 (Press Release), which is not included in the input content.
Investor Verification Checklist
- Verify the content of Exhibit 99.1 (Press Release) to obtain the actual financial results or operational updates intended for this filing.
- Confirm the discrepancy between the requested company name "Akso Health Group" and the registrant name "Hexindai Inc." listed on the Form 6-K.
- Review the full press release for any material events, risks, or guidance that triggered this report.